FULC logo

Fulcrum Therapeutics (FULC) Company Overview

Profile

Full Name:

Fulcrum Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

July 18, 2019

Indexes:

Not included

Description:

Fulcrum Therapeutics is a biotechnology company focused on developing innovative therapies for genetic diseases. They use their proprietary gene modulation technology to target and treat conditions caused by genetic mutations, aiming to improve patients' lives through advanced treatments and research.

Events Calendar

Earnings

Next earnings date:

Feb 27, 2025

Recent quarterly earnings:

Nov 13, 2024

Recent annual earnings:

Feb 27, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Nov 14, 24 RBC Capital
Sector Perform
Nov 14, 24 HC Wainwright & Co.
Neutral
Sep 13, 24 RBC Capital
Sector Perform
Sep 13, 24 HC Wainwright & Co.
Neutral
Sep 12, 24 Stifel
Hold
Sep 12, 24 Leerink Partners
Market Perform
Sep 12, 24 Cantor Fitzgerald
Neutral
Sep 12, 24 B of A Securities
Underperform
Sep 9, 24 B of A Securities
Neutral
Aug 1, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Fulcrum Therapeutics?
  • Does Fulcrum Therapeutics pay dividends?
  • What sector is Fulcrum Therapeutics in?
  • What industry is Fulcrum Therapeutics in?
  • What country is Fulcrum Therapeutics based in?
  • When did Fulcrum Therapeutics go public?
  • Is Fulcrum Therapeutics in the S&P 500?
  • Is Fulcrum Therapeutics in the NASDAQ 100?
  • Is Fulcrum Therapeutics in the Dow Jones?
  • When was Fulcrum Therapeutics's last earnings report?
  • When does Fulcrum Therapeutics report earnings?
  • Should I buy Fulcrum Therapeutics stock now?

What is the ticker symbol for Fulcrum Therapeutics?

The ticker symbol for Fulcrum Therapeutics is NASDAQ:FULC

Does Fulcrum Therapeutics pay dividends?

No, Fulcrum Therapeutics does not pay dividends

What sector is Fulcrum Therapeutics in?

Fulcrum Therapeutics is in the Healthcare sector

What industry is Fulcrum Therapeutics in?

Fulcrum Therapeutics is in the Biotechnology industry

What country is Fulcrum Therapeutics based in?

Fulcrum Therapeutics is headquartered in United States

When did Fulcrum Therapeutics go public?

Fulcrum Therapeutics's initial public offering (IPO) was on July 18, 2019

Is Fulcrum Therapeutics in the S&P 500?

No, Fulcrum Therapeutics is not included in the S&P 500 index

Is Fulcrum Therapeutics in the NASDAQ 100?

No, Fulcrum Therapeutics is not included in the NASDAQ 100 index

Is Fulcrum Therapeutics in the Dow Jones?

No, Fulcrum Therapeutics is not included in the Dow Jones index

When was Fulcrum Therapeutics's last earnings report?

Fulcrum Therapeutics's most recent earnings report was on Nov 13, 2024

When does Fulcrum Therapeutics report earnings?

The next expected earnings date for Fulcrum Therapeutics is Feb 27, 2025

Should I buy Fulcrum Therapeutics stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions